The Strategic Questions Reshaping the CDMO Map
January 22, 2026
We sit down with Joerg Ahlgrimm, CEO of SK pharmteco, to discuss his career and the changing landscape for outsourcing
9 min read
False
January 22, 2026
We sit down with Joerg Ahlgrimm, CEO of SK pharmteco, to discuss his career and the changing landscape for outsourcing
9 min read
By Andrew Lewis
January 20, 2026
Decades of research have made mRNA a platform for fast, flexible therapeutic innovation, but its promise depends on partnerships.
4 min read
By Joe Renny
January 14, 2026
For CDMOs, the storms of de-industrialization, Brexit, and the Biosecure Act are not existential threats but the very winds that can propel them forward.
4 min read
By J.D. Mowery
December 4, 2025
So, you’re at the stage where you need a CDMO. Some partnerships work and others fail. Here’s what I’ve learned about trust from my experience.
5 min read
November 13, 2025
We get the lowdown on Kindeva’s new, multi-use facility in Bridgeton and trends in the market.
November 10, 2025
Expanded collaboration between Recipharm Advanced Bio and the UK’s University of Oxford targets vaccine candidates for malaria
4 min read
By Stephen Corson
November 5, 2025
Clinical trials are becoming more complex. And not all CROs are able to step up.
3 min read
By Santosh Vijay, Dave Nirschl
October 1, 2025
Laying the conceptual foundation for digital transformation – with a glimpse of how it is taking shape today
6 min read
By Stephanie Vine
August 26, 2025
We sit down with the Chief Scientific Officer of BioDuro to find out what he wanted to be as a child and how he came to love drug development.
10 min read
By Stephanie Vine
June 5, 2025
Is the complexity of the fill-finish process under appreciated in pharma manufacturing? Four experts discuss why it’s important to get fill-finish right, and what ideal processes should look like.
7 min read
False
False
False